Genetic downregulation of receptor‐interacting protein 140 uncovers the central role of Akt signalling in the regulation of fatty acid oxidation in skeletal muscle cells

Abstract

New findings r What is the central question of this study?Receptor-interacting protein 140 (RIP140) is a known negative regulator of oxidative capacity. However, the effects of its downregulation on insulin-mediated fatty acid metabolism and of gene expression and Akt-atypical protein kinase C-ζ signalling in skeletal muscle remain incomplete. r What is the main finding and its importance?Our data indicate that downregulation of RIP140 significantly impacts both basal and insulin-mediated activation of Akt and atypical protein kinase C-ζ. This extends the assigned regulatory role of these signalling intermediates during insulin stimulation and suggests that Akt may also be an important regulator of fatty acid oxidation in basal conditions. The role of the nuclear co-repressor receptor-interacting protein 140 (RIP140) in metabolic regulation, gene and protein expression and insulin signalling in skeletal muscle cells remains to be delineated. To study this question, L6 myotubes were treated with or without an RNA interference oligonucleotide sequence to downregulate RIP140 expression and incubated with or without insulin (1 μm). Downregulation of RIP140 increased (P < 0.05) basal palmitate uptake (by 20%) and decreased (P < 0.05) basal palmitate oxidation (by 38%). In control small interfering RNA-treated cells, insulin increased (P < 0.05) glucose (by 31%) and palmitate uptake (by 20%) and decreased (P < 0.05) palmitate oxidation (by 35%). However, in RIP140 small interfering RNA-treated cells, insulin did not affect (P > 0.05) palmitate uptake and increased (P < 0.05) palmitate oxidation (by 79%). In insulin-mediated conditions, downregulation of RIP140 decreased (P < 0.05) Akt Ser473 and atypical protein kinase C-ζ Thr403/410 phosphorylation. As expected, downregulation of RIP140 was accompanied by an increase (P < 0.05) in cytochrome c oxidase subunit 4 isoform 1 and peroxisome proliferator-activated receptor receptor γ coactivator-1α mRNA content. Downregulation of RIP140 increased (P < 0.05) fatty acid transport protein 1 mRNA content and carnitine palmitoyltransferase 1b protein content and decreased (P < 0.05) medium chain acyl-CoA dehydrogenase mRNA content in basal conditions. In insulin-mediated conditions, downregulation of RIP140 increased (P < 0.05) carnitine palmitoyltransferase 1b, fatty acid transport protein 1 and fibroblast growth factor 21 mRNA content and decreased (P < 0.05) medium chain acyl-CoA dehydrogenase mRNA content and plasma membrane fatty acid translocase/cluster of differentiation 36 protein content.

New Target Genes in Endometrial Tumors Show a Role for the Estrogen-Receptor Pathway in Microsatellite-Unstable Cancers

“…The authors identify NRIP1 as the nearest gene to one of the three loci and point out the relevance of this gene for estrogen‐responsive tumors [Ghoussaini et al., ]. All in all, NRIP1 appears as a promising gene, as several recent studies have been pointing out its importance for several cellular and biochemical mechanisms, including cancer‐related pathways [Fritah et al., ; Ho et al., ; Constantinescu and Turcotte, ]. Moreover, the high exposure to estrogens is currently considered the major risk factor for EC.…”

The Effects of AS160 Modulation on Fatty Acid Transporters Expression and Lipid Profile in L6 Myotubes

“…Reduction of AS160 gene expression was done using gene silencing method according to the manufacturer recommendations (Lifetechnologies, former Invitrogen) [29]. The day before transfection L6 myotubes were transferred to growth medium without antibiotics such that they were ~60% confluent at the time of transfection.…”

Modest Decrease in Pgc1α Results in TAG Accumulation but not in Insulin Resistance in L6 Myotubes

“…Gene silencing (siRNA) Reduction of PGC-1α gene expression was performed using gene silencing method according to manufacturer protocol (Lifetechnologies, former Invitrogen) [20]. The day before transfection cells (L6 myotubes) were transferred to growth medium without antibiotics.…”